Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Dow
Baxter
AstraZeneca
Mallinckrodt

Last Updated: May 26, 2022

Drug Sales Trends for ATORVASTATIN


✉ Email this page to a colleague

« Back to Dashboard

Payment Methods and Pharmacy Types for ATORVASTATIN (2019)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $361,112,892
INSIDE ANOTHER STORE $724,807,214
[disabled in preview] $2,522,092,090
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 12,293,219
INSIDE ANOTHER STORE 28,495,994
[disabled in preview] 65,589,562
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $317,309,479
MEDICARE $1,851,011,763
[disabled in preview] $1,457,072,954
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ATORVASTATIN
Drug Units Sold Trends for ATORVASTATIN

Annual Sales Revenues and Units Sold for ATORVASTATIN

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ATORVASTATIN See Plans and Pricing See Plans and Pricing 2019
ATORVASTATIN See Plans and Pricing See Plans and Pricing 2018
ATORVASTATIN See Plans and Pricing See Plans and Pricing 2017
ATORVASTATIN See Plans and Pricing See Plans and Pricing 2016
>Drug Name >Revenues (USD) >Units >Year

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
AstraZeneca
Boehringer Ingelheim
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.